Viking Therapeutics (VKTX) Leases (2019 - 2025)
Historic Leases for Viking Therapeutics (VKTX) over the last 7 years, with Q3 2025 value amounting to $666000.0.
- Viking Therapeutics' Leases fell 4016.17% to $666000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $666000.0, marking a year-over-year decrease of 4016.17%. This contributed to the annual value of $1.0 million for FY2024, which is 1092.36% down from last year.
- Per Viking Therapeutics' latest filing, its Leases stood at $666000.0 for Q3 2025, which was down 4016.17% from $780000.0 recorded in Q2 2025.
- Over the past 5 years, Viking Therapeutics' Leases peaked at $1.6 million during Q1 2022, and registered a low of $25000.0 during Q4 2021.
- Its 5-year average for Leases is $951473.7, with a median of $1.1 million in 2024.
- As far as peak fluctuations go, Viking Therapeutics' Leases tumbled by 9221.18% in 2021, and later surged by 557200.0% in 2022.
- Quarter analysis of 5 years shows Viking Therapeutics' Leases stood at $25000.0 in 2021, then surged by 5572.0% to $1.4 million in 2022, then decreased by 20.59% to $1.1 million in 2023, then fell by 10.92% to $1.0 million in 2024, then crashed by 33.6% to $666000.0 in 2025.
- Its Leases stands at $666000.0 for Q3 2025, versus $780000.0 for Q2 2025 and $892000.0 for Q1 2025.